Trials / Completed
CompletedNCT00722241
Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (actual)
- Sponsor
- DexCom, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of the next-generation DexCom SEVEN Continuous Glucose Monitoring System (SEVEN.2 System) when worn for up to 7-days by subjects \>18 years-old with diabetes mellitus requiring insulin therapy.
Conditions
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-06-01
- Completion
- 2008-07-01
- First posted
- 2008-07-25
- Last updated
- 2008-07-25
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00722241. Inclusion in this directory is not an endorsement.